Title Gliflozino Module 1_T2DM_T395_20250209 Day 2.pdf ✅

Diabetes Module Gliflozino Induction Training By: Rawda Mahmoud MSL 09 -02 -2025 GLIFL. Diab_T395_20250209
Module Items: Management of T2DM T2DM Diabetes Introduction Glucose Metabolism Guidelines Dapagliflozin Clinical trial
Pathophysiology Decreased insulin secretion Increased FFA production Increased endogenous glucose secretion Inefficient glucose uptake Increased glucagon secretion Increased glucose reabsorption Decreased incretin effect Neurotransmitter dysfunction Pancreatic Beta cells Adipose Tissue Liver Muscles Pancreatic Alpha cells Kidney Digestive tract Nervous system T2DM
Pathophysiology: Incretin Hormones Effect